Once activated, Akt initiates downstream signaling cascades, including phosphorylation of mTOR and activation of NF-κB, thereby promoting tumor growth, enhancing chemoresistance, and inhibiting apoptosis (Tang et al., 2022; Ha et al., 2021; Buontempo et al., 2011). The gene discussed is AKT1; the disease is neoplasm.